Sales of the TAC-STIM product decreased by 32%, highlighting potential challenges in that segment of the business. ElectroCore reported total net sales of $25.2 million for the full year 2024 ...
Truvaga Sales: $2.8 million for 2024, a 174% increase over 2023. TAC-STIM Sales: $1.2 million for 2024, down from $1.7 million in 2023. Operating Expenses: $33.6 million for 2024, compared to $32. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback